Today's top medical abstracts
Oncology
Become a Member Today!
Email
Password
Remember me
Forgot your Password?

Invite Code?

Home
General Oncology
For Practicing
Oncologists
Conferences
Jobs
Newsletters
My Library
Topics in
Oncology
        Alternative Therapies
        Anemia/Polycythemia
        BMT/SCT
        Basic Science/Genetics
        Bone/Cartilage
        Breast
        Carcinogenesis
        Coagulation/Bleeding Dz
        Colorectal Cancer/Polyps
        Dermatologic Oncology
        Diagnostics/Radiology
        Economics of Medicine
        Endocrine Oncology
        GI Oncology
        Gynecologic Oncology
        Head and Neck
        Hepatobiliary/Pancreas
        Leukemia/Lymphoma
        Lung/Thoracic Oncology
        Myeloproliferative Dz
        Neurologic Oncology
        Pain/Palliative Care
        Pediatric Heme/Oncology
        Pharmacology/Therapy
        Popular Press
        Renal/Urologic
        Side Effects
        Soft Tissue/Sarcoma
        Transfusion Medicine
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
 
Sponsor
For Practicing Oncologists
Technology Advances: Next-Generation Diagnostics Offer On-the-Spot Results
Dorothy J. Schirf, MD, MDLinx Oncology
Off-Label Use: Sitting In Limbo
Roberta Buell, MBA, Sausalito Healthcare Partners
Clinical Trial Watch: Trial Finds Virtual Colonoscopy Comparable to Standard Colonoscopy
Tracy Hampton, PhD, MDLinx Oncology
  See all
breast cancer;lymph node dissection Article Summary

Click the title below to leave the MDLinx Network and go to the Journal's Website
How many sentinel lymph nodes are enough during sentinel lymph node dissection for breast cancer?
Cancer, 06/17/08
Print     Email This Article     Save in My Library   Free Abstract
Yi M et al. – Removal of a maximum of 5 sentinel lymph nodes (SLNs) allowed recovery of >99% of positive SLNs in breast cancer pts; tumor histology, pt race, and tumor size and location may influence this number

Methods

  • Study of how many SLNs must be removed for accurate lymph node staging and which pt and tumor characteristics influence this number
  • Review of data for clinical tumor type, lymph node, metastasis (TNM) T1 through T3, N0, M0 breast cancer for pts who has lymphatic mapping, including 777 pts who had at least 1 SLN positive for cancer
  • Simple and multiple quantile regression analyses for association of pt and tumor characteristics with number of positive SLNs
  • Determination of baseline number of dissected SLNs to detect 99% of positive SLNs in all pts

Results
  • Mean number of SLNs removed in 777 lymph node+ pts: 2.9 (range, 1-13 SLNs)
  • >99% of positive SLNs identified in first 5 lymph nodes removed
  • On univariate analysis, tumor histology, pt race, tumor location, and tumor size significantly affected number of SLNs needed to be removed to identify 99% of all positive SLNs
  • On multivariate analysis, mixed ductal and lobular histology, Caucasian race, inner quadrant tumor location, and T1 tumor classification significantly increased this needed-for-removal number of SLNs

Sponsor
Read a Different Specialty
Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pediatrics
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology
Profession Index
Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2008 MDLinx, Inc.